CN107308421A - A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae - Google Patents

A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae Download PDF

Info

Publication number
CN107308421A
CN107308421A CN201710317112.3A CN201710317112A CN107308421A CN 107308421 A CN107308421 A CN 107308421A CN 201710317112 A CN201710317112 A CN 201710317112A CN 107308421 A CN107308421 A CN 107308421A
Authority
CN
China
Prior art keywords
parts
deficiency
chinese medicine
medicine composition
apoplexy sequelae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710317112.3A
Other languages
Chinese (zh)
Inventor
汪洪
郑�硕
程丽娟
毛小红
吕凌云
徐伟
杜佰意
刘孟元
杨威
能晔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yingshan county people's hospital
Original Assignee
Yingshan county people's hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yingshan county people's hospital filed Critical Yingshan county people's hospital
Priority to CN201710317112.3A priority Critical patent/CN107308421A/en
Publication of CN107308421A publication Critical patent/CN107308421A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, including following component in parts by weight：60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, 10 parts of polygala, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, reasonable selection Chinese medicine composition, above component convenient material drawing, cheap, curative effect is reliable, and long-term taking there will not be toxic side effect, effectively blood stagnancy due to deficiency of QI type apoplexy sequelae can be treated, improve patient.

Description

A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae
Technical field
The present invention relates to a kind of Chinese medicine, more particularly, to a kind of Chinese medicine group for being used to treat blood stagnancy due to deficiency of QI type apoplexy sequelae Compound.
Background technology
Apoplexy sequelae refers to the sequelae that paralytic is suffered from, and mainly includes the crooked, decrease of memory of face mouthful, swallows Difficult, speech is not smooth, body numbness even hemiplegia etc..Treat apoplexy sequelae and mainly use science diet, passive recovery Take exercise and medicine auxiliary treatment, improve the factor of atherogenesis, reduce blood viscosity, anti-tampon shape again Into preventing illness from further developing.
It is usually based on Western medicine, but to be to determine it is also obvious that there is drug resistance, drug effect at present for apoplexy sequelae Can gradually it reduce, taking dose more and more significantly, to the toxic effect of patient body, is not suitable for long-term taking etc..Treatment by Chinese herbs The disadvantages mentioned above of Western medicine is not present in apoplexy sequelae, and reasonable compatibility traditional Chinese medicinal components can not only mitigate patient's pain, therapeutic effect Effective guarantee can be obtained.Therefore, it is necessary to develop a kind of Chinese medicine for treating apoplexy sequelae.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, can effectively it control Blood stagnancy due to deficiency of QI type apoplexy sequelae is treated, and is had no toxic side effect.
In order to solve the above-mentioned technical problem, the technical solution adopted by the present invention is：One kind is treated after blood stagnancy due to deficiency of QI type apoplexy Lose the Chinese medicine composition of disease, including following component in parts by weight：60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, Radix Angelicae Sinensis 12 Part, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, 10 parts of polygala, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, teasel root 8 Part, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.
During the medicine preparation, after above-mentioned each component is weighed by weight, pulvis is made and swallows, or adds water to cook two It is secondary, take twice within 1st.
In the component of the present invention, the Radix Astragali has the effects such as enhancing immunity of organisms, anti-aging, decompression；Ginseng is considered as hundred The king of grass, sweet micro- sweat, main tonifying five zang organs unsaturated vapor, soothe the nerves can expand capillary, stimulate circulation；Jujube kernel has flat Liver and qi, the effect moistened the lung and nourish yin, can intelligence development breathe out surely, hearing-improing and eyesight improving；Radix Angelicae Sinensis has effects that promoting blood circulation and removing blood stasis, menstruction regulating and pain relieving；Bavin It is always the important drugs for treating apoplexy recklessly, moreover it is possible to prevent and treat senile dementia；Fry rattletop can dispelling wind and relieving convulsion, control head wind headache, limbs The diseases such as the not smoothgoing plug of numbness, hemiplegia, language；Polygala can tranquilize the mind and promote the intelligence, nourishing heart blood, relieving convulsion, to deficiency of heart-QI, the five internal organs are not enough, brain Wind headache, forgetful it be scared, absent-minded have good curative effect；Dried rehamnnia root can be enriched blood with nourishing Yin and promoting production of body fluid, cool blood, be passed through less for blood Close, the disease such as the micro- Huang of the deficiency of blood；The bighead atractylodes rhizome has calm, expansion blood vessel, anticoagulant, improves immunity, anti-oxidant and other effects；Rubia grass is dispelled The stasis of blood is stimulated the menstrual flow, effect of activating blood circulation；Exocarpium Citri Rubrum energy row dissipating bind, straight trip decline, and are sharp gas key medicine；Gas can be discontinuously helped, blood vessels are adjusted, it is raw New blood, breaks extravasated blood, long term usage energy benefiting energy；Edible tulip can be with clearing heat and detoxicating, dispersing swelling and dissipating binds, treatment ulcer malignant sore；Leech, which has, to be controlled The effects such as apoplexy, hypertension, desilting is treated, with very high medical value；Ginger warming spleen and stomach for dispelling cold, Back to Yang Tongmai, can invigorating qi and refreshing.
The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, reasonable selection Chinese medicine composition, above component Convenient material drawing, cheap, curative effect is reliable, and long-term taking there will not be toxic side effect, can be effectively to blood stagnancy due to deficiency of QI type apoplexy Sequelae is treated, and improves patient.
Embodiment
Below in conjunction with specific embodiment, technical scheme is clearly and completely described, it is clear that retouched The embodiment stated is only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, sheet The every other embodiment that field those of ordinary skill is obtained under the premise of creative work is not made, belongs to the present invention The scope of protection.
The Chinese medicine composition of the treatment blood stagnancy due to deficiency of QI type apoplexy sequelae, including following component in parts by weight：The Radix Astragali 60 parts, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, fry 20 parts of rattletop, 10 parts of polygala, 16 parts of dried rehamnnia root, the bighead atractylodes rhizome 15 parts, rubia grass 12 parts, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, 5 parts of ginger.
After said components are weighed accurately, the weight ratio of the weight twice, added water twice that adds water and Chinese medicine is 9:1、7:1 decocts Decoction is cooked into, is taken twice within 1st；Medicine can also be worn into powdery, and water is swallowed.
Curative effect is carried out from medicine prepared by technical solution of the present invention, 88 blood stagnancy due to deficiency of QI of certain county people's hospital are chosen The patient of type apoplexy sequelae is verified, is drunk twice within one day, continuous use three months.The result is as follows：
Patient numbers Treat efficiently individual quantity The invalid number for the treatment of Total effective rate
88 people 81 people 7 people 92.1%
By above treatment results it can be found that the treatment blood stagnancy due to deficiency of QI type Chinese medicine composition is to blood stagnancy due to deficiency of QI type apoplexy sequelae With good improvement, total effective rate is more than 92%.
Finally it is pointed out that above embodiment is only the more representational example of the present invention.Obviously, it is of the invention Above-mentioned embodiment is not limited to, there can also be many deformations.Every technical spirit according to the present invention specific reality to more than Any simple modification, equivalent variations and modification that the mode of applying is made, are considered as belonging to protection scope of the present invention.

Claims (1)

1. a kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae, it is characterized in that the Chinese medicine composition is included with weight The following component of part meter：60 parts of the Radix Astragali, 18 parts of ginseng, 30 parts of jujube kernel, 12 parts of Radix Angelicae Sinensis, 16 parts of radix bupleuri, 20 parts of rattletop of stir-fry, polygala 10 Part, 16 parts of dried rehamnnia root, 15 parts of the bighead atractylodes rhizome, 12 parts of rubia grass, 10 parts of Exocarpium Citri Rubrum, 8 parts of teasel root, 8 parts of edible tulip, 20 parts of leech, ginger 5 Part.
CN201710317112.3A 2017-05-08 2017-05-08 A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae Pending CN107308421A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710317112.3A CN107308421A (en) 2017-05-08 2017-05-08 A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710317112.3A CN107308421A (en) 2017-05-08 2017-05-08 A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae

Publications (1)

Publication Number Publication Date
CN107308421A true CN107308421A (en) 2017-11-03

Family

ID=60184847

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710317112.3A Pending CN107308421A (en) 2017-05-08 2017-05-08 A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae

Country Status (1)

Country Link
CN (1) CN107308421A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933200A (en) * 2014-01-14 2014-07-23 李承文 Traditional Chinese medicine composition for treating apoplexy sequela
CN104208643A (en) * 2014-09-25 2014-12-17 刘建忠 Chinese medicine for treating hemiplegia and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933200A (en) * 2014-01-14 2014-07-23 李承文 Traditional Chinese medicine composition for treating apoplexy sequela
CN104208643A (en) * 2014-09-25 2014-12-17 刘建忠 Chinese medicine for treating hemiplegia and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
万春等: "补中益气汤治疗中风后遗症32例", 《中医研究》 *
李国琳等: ""补中益气汤加三七冰片治疗中风痴呆病40例"", 《四川中医》 *
杨生贵，杨发坤: "中风病治疗体会", 《甘肃中医学院学报》 *

Similar Documents

Publication Publication Date Title
CN103536889B (en) One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction
CN101229267A (en) Medicine compounds for pulmonary and rheumatic heart disease and preparing method thereof
CN105343645A (en) External traditional Chinese medicine ointment for treating verruca plana
CN103385941B (en) Chinese herbal medicine analgesic moxibustion
CN104383460A (en) Traditional Chinese medicine powder for treating insomnia
CN103230535A (en) Medicinal liquor with function of activating collaterals to ease pain
CN106511773A (en) Traditional Chinese medicine composite for treating dental ulcer
CN105878627A (en) Traditional Chinese medicine formula for treating myopic disease
CN107308421A (en) A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae
CN104547916A (en) Traditional Chinese medicine decoction for treating coronary heart disease
CN103055172A (en) Chinese medicinal composition for treating leucoderma
CN104258295A (en) Traditional Chinese medicine decoction for treating lymphoma
CN103990019A (en) Traditional Chinese medicine preparation for treating light-headedness
CN107412512A (en) A kind of pharmaceutical composition for treating varix of lower limb
CN103340975A (en) Traditional Chinese medicine for treating duodenal ulcer
CN103893675A (en) Traditional Chinese medicinal preparation for treating epigastric pain
CN106728973A (en) A kind of Chinese medicinal capsule for treating cervical spondylopathy
CN106177663A (en) A kind of Chinese medicine composition for treating verruca plana
CN106511698A (en) Traditional Chinese medicine for treating hypertension
CN101596299A (en) A kind of Chinese medicine pill for the treatment of precancerous lesions of chronic atrophic gastritis
CN105412612A (en) Medicine for treating insomnia
CN106215040A (en) A kind of Chinese medicine composition treating asthma
CN105125949A (en) Chinese drug preparation for treating syndromes after cholecystotomy
CN104740193A (en) Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition
CN104623549A (en) Traditional Chinese medicine preparation for treating costal chondritis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171103